MX355416B - Biomarcadores de cancer de pulmon y usos de los mismos. - Google Patents

Biomarcadores de cancer de pulmon y usos de los mismos.

Info

Publication number
MX355416B
MX355416B MX2014004860A MX2014004860A MX355416B MX 355416 B MX355416 B MX 355416B MX 2014004860 A MX2014004860 A MX 2014004860A MX 2014004860 A MX2014004860 A MX 2014004860A MX 355416 B MX355416 B MX 355416B
Authority
MX
Mexico
Prior art keywords
individual
cancer
lung cancer
biomarkers
methods
Prior art date
Application number
MX2014004860A
Other languages
English (en)
Other versions
MX2014004860A (es
Inventor
Alaric Williams Stephen
Riel-Mehan Michael
N Brody Edward
A E Stewart Alex
M Ostroff Rachel
Original Assignee
Somalogic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Somalogic Inc filed Critical Somalogic Inc
Publication of MX2014004860A publication Critical patent/MX2014004860A/es
Publication of MX355416B publication Critical patent/MX355416B/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57423—Specifically defined cancers of lung
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Abstract

La presente invención se refiere a un método para diagnosticar cáncer de pulmón amicrocítico (NSCLC) en un individuo, caracterizado porque comprende: medir el nivel de anhidrasa carbónica VI (CA6) en una muestra biológica obtenida del individuo, en donde el nivel de CA6 proporciona una indicación de si el individuo tiene o no cáncer de pulmón.
MX2014004860A 2011-10-24 2011-10-24 Biomarcadores de cancer de pulmon y usos de los mismos. MX355416B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2011/057499 WO2013062515A2 (en) 2011-10-24 2011-10-24 Lung cancer biomarkers and uses thereof

Publications (2)

Publication Number Publication Date
MX2014004860A MX2014004860A (es) 2014-05-27
MX355416B true MX355416B (es) 2018-04-18

Family

ID=48168748

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014004860A MX355416B (es) 2011-10-24 2011-10-24 Biomarcadores de cancer de pulmon y usos de los mismos.

Country Status (15)

Country Link
EP (1) EP2771692B1 (es)
JP (1) JP5986638B2 (es)
KR (1) KR101921945B1 (es)
CN (2) CN106168624B (es)
AU (1) AU2011378427B8 (es)
BR (1) BR112014006432B8 (es)
CA (3) CA3006793C (es)
ES (1) ES2674318T3 (es)
IL (2) IL231426A (es)
IN (1) IN2014CN01787A (es)
MX (1) MX355416B (es)
NZ (1) NZ621733A (es)
SG (1) SG11201400375SA (es)
WO (1) WO2013062515A2 (es)
ZA (1) ZA201401476B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130116150A1 (en) 2010-07-09 2013-05-09 Somalogic, Inc. Lung Cancer Biomarkers and Uses Thereof
CA2910327A1 (en) * 2013-05-09 2014-11-13 Rui Li Method and system for assessing health condition
EP3174993B1 (en) 2014-07-30 2023-12-06 President and Fellows of Harvard College Probe library construction
CN104263723B (zh) * 2014-09-15 2017-06-06 南京医科大学 一种与原发性肺癌辅助诊断相关的低频高外显性遗传标志物及其应用
WO2016094330A2 (en) * 2014-12-08 2016-06-16 20/20 Genesystems, Inc Methods and machine learning systems for predicting the liklihood or risk of having cancer
CN108026584B (zh) * 2015-09-11 2021-12-10 适体科学株式会社 非小细胞肺癌诊断用蛋白质生物标志物组及利用其的非小细胞肺癌诊断方法
WO2017075784A1 (zh) * 2015-11-05 2017-05-11 深圳华大基因研究院 肺腺癌生物标记物及其应用
KR101853118B1 (ko) * 2016-09-02 2018-04-30 주식회사 바이오인프라생명과학 피험체의 폐암 진단을 위한 복합 바이오마커군, 이를 이용하는 폐암 진단용 키트, 복합 바이오마커군의 정보를 이용하는 방법 및 이를 수행하는 컴퓨팅 시스템
WO2018089445A1 (en) * 2016-11-08 2018-05-17 President And Fellows Of Harvard College Matrix imprinting and clearing
CN110402394B (zh) * 2017-03-01 2024-04-26 豪夫迈·罗氏有限公司 用于将关于分析物的存在的生物样品进行分类的系统和方法
WO2018218150A1 (en) 2017-05-26 2018-11-29 President And Fellows Of Harvard College Systems and methods for high-throughput image-based screening
CN109116023B (zh) * 2018-06-14 2021-06-04 郑州大学第一附属医院 一种肺癌标志物抗-mmp12自身抗体及其应用
CN109470859A (zh) * 2018-11-04 2019-03-15 华东医院 一种外泌体蛋白作为鉴别肺结节良恶性标志物及其应用
EP3924974A4 (en) * 2019-02-15 2022-11-16 Biodesix, Inc. PREDICTIVE TEST TO IDENTIFY EARLY-STAGE NSCLC PATIENTS WITH HIGH RISK OF RECURRENCE POST-SURGERY
CN110473167B (zh) * 2019-07-09 2022-06-17 哈尔滨工程大学 一种基于深度学习的尿沉渣图像识别系统及方法
CN112892619B (zh) * 2019-12-04 2022-07-15 香港城市大学深圳研究院 弧形边缘截面的pdms母模、微流控阀和芯片及其制备
KR102613772B1 (ko) * 2021-02-02 2023-12-14 제노마인(주) 폐암 혈액 바이오마커의 검출 방법 및 키트

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000052204A2 (en) * 1999-02-22 2000-09-08 Orntoft Torben F Gene expression in bladder tumors
US6596503B1 (en) * 2000-08-18 2003-07-22 East Carolina University Monoclonal antibody DS6, tumor-associated antigen CA6, and methods of use thereof
JP4874234B2 (ja) * 2004-08-10 2012-02-15 オンコセラピー・サイエンス株式会社 非小細胞肺癌関連遺伝子ＡＮＬＮ、およびそのＲｈｏＡとの相互作用
EP2305811A1 (en) * 2005-07-27 2011-04-06 Oncotherapy Science, Inc. Method of diagnosing smal cell lung cancer
EP1937837A2 (en) * 2005-07-29 2008-07-02 Siemens Healthcare Diagnostics Inc. Methods and kits for the prediction of therapeutic success, recurrence free and overall survival in cancer therapies
US8445198B2 (en) 2005-12-01 2013-05-21 Medical Prognosis Institute Methods, kits and devices for identifying biomarkers of treatment response and use thereof to predict treatment efficacy
US8014957B2 (en) * 2005-12-15 2011-09-06 Fred Hutchinson Cancer Research Center Genes associated with progression and response in chronic myeloid leukemia and uses thereof
WO2008046911A2 (en) * 2006-10-20 2008-04-24 Exiqon A/S Novel human micrornas associated with cancer
GB0803192D0 (en) * 2008-02-22 2008-04-02 Mubio Products Bv SCLC biomarker panel
US10359425B2 (en) * 2008-09-09 2019-07-23 Somalogic, Inc. Lung cancer biomarkers and uses thereof
WO2010030697A1 (en) * 2008-09-09 2010-03-18 Somalogic, Inc. Lung cancer biomarkers and uses thereof
CA3153682A1 (en) 2008-11-17 2010-05-20 Veracyte, Inc. Methods and compositions of molecular profiling for disease diagnostics
EP2370813A4 (en) 2008-12-04 2012-05-23 Univ California MATERIALS AND METHODS FOR DIAGNOSIS AND PROGNOSIS OF PROSTATE CANCER
WO2011100472A1 (en) * 2010-02-10 2011-08-18 The Regents Of The University Of California Salivary transcriptomic and proteomic biomarkers for breast cancer detection
CA2791905A1 (en) 2010-03-01 2011-09-09 Caris Life Sciences Luxembourg Holdings, S.A.R.L. Biomarkers for theranostics
AU2011237669B2 (en) 2010-04-06 2016-09-08 Caris Life Sciences Switzerland Holdings Gmbh Circulating biomarkers for disease

Also Published As

Publication number Publication date
CN106168624B (zh) 2018-03-13
CA3064363C (en) 2022-05-17
ES2674318T3 (es) 2018-06-28
AU2011378427A1 (en) 2013-05-16
KR101921945B1 (ko) 2018-11-26
IN2014CN01787A (es) 2015-05-29
WO2013062515A3 (en) 2014-04-17
KR20140082840A (ko) 2014-07-02
CN103890586B (zh) 2016-06-29
BR112014006432B1 (pt) 2021-04-06
WO2013062515A2 (en) 2013-05-02
CA3006793C (en) 2020-02-18
IL252163A0 (en) 2017-07-31
JP5986638B2 (ja) 2016-09-06
AU2011378427A8 (en) 2015-08-27
BR112014006432B8 (pt) 2022-10-25
IL231426A (en) 2017-06-29
EP2771692A4 (en) 2015-08-26
NZ621733A (en) 2015-05-29
CN106168624A (zh) 2016-11-30
ZA201401476B (en) 2016-06-29
CA2847188A1 (en) 2013-05-02
SG11201400375SA (en) 2014-04-28
AU2011378427B2 (en) 2015-07-16
AU2011378427B8 (en) 2015-08-27
EP2771692B1 (en) 2018-04-18
EP2771692A2 (en) 2014-09-03
CA2847188C (en) 2020-02-18
IL231426A0 (en) 2014-04-30
CA3006793A1 (en) 2013-05-02
BR112014006432A2 (pt) 2017-04-04
CN103890586A (zh) 2014-06-25
MX2014004860A (es) 2014-05-27
JP2015501154A (ja) 2015-01-15
CA3064363A1 (en) 2013-05-02

Similar Documents

Publication Publication Date Title
MX2014004860A (es) Biomarcadores de cancer de pulmon y usos de los mismos.
MX2013001042A (es) Biomarcadores de cancer pancreatico y usos de los mismos.
MX355020B (es) Biomarcadores de cancer de pulmon y usos de los mismos.
EP3029153A3 (en) Mesothelioma biomarkers and uses thereof
MX2020004617A (es) Prediccion de riesgo de evento cardiovascular y usos del mismo.
GB2478441A (en) Lung cancer biomarkers and uses thereof
WO2014160275A3 (en) Biomarkers for liver fibrosis
EP2566983A4 (en) SERIAL ANALYSIS OF BIOMARKERS FOR THE DIAGNOSIS OF A DISEASE
EA030186B9 (ru) Способ проведения количественных анализов
NZ605698A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2008128043A3 (en) Diagnostic and prognostic methods for renal cell carcinoma
WO2015095862A3 (en) Microrna biomarkers for ovarian cancer
EA201500080A1 (ru) Способ in vitro диагностирования и мониторинга рака
WO2012170206A3 (en) Color-producing diagnostic systems, reagents and methods
EP3135774A3 (en) Complex sets of mirnas as non-invasive biomarkers for kidney cancer
NZ608316A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2013028807A3 (en) Renal cell carcinoma biomarkers and uses thereof
WO2011137388A3 (en) Identification and use of biomarkers for detection and quantification of the level of radiation exposure in a biological sample
WO2015189591A3 (en) Method and arrays for use in diagnosing early breast cancer
NZ601648A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2012139052A3 (en) Antibody biomarkers for diabetes
WO2015023503A3 (en) Compositions and methods for multimodal analysis of cmet nucleic acids
EP3557259A3 (en) Methods and arrays for use in the same
WO2012054824A3 (en) Prognostic biomarkers in patients with ovarian cancer
WO2012135620A3 (en) Molecular gram stain

Legal Events

Date Code Title Description
FG Grant or registration